Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

FINGOLIMOD SALA 0,5 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/FINGOLIMOD SALA 0,5 MG CAPSULAS DURAS EFG

Approved

STANDARD

FINGOLIMOD SALA 0,5 MG CAPSULAS DURAS EFG

Laboratorio Reig Jofre, S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Dec 22, 2020
Approval ID: 81a6fd09ffd6fc8c
Company: Laboratorio Reig Jofre, S.A.
Type: Standard

Approval Details

Approval Id: 81a6fd09ffd6fc8c
Drug Cima Aemps Name: FINGOLIMOD SALA 0,5 MG CAPSULAS DURAS EFG
Register Number: 85336
Holder Company Name: Laboratorio Reig Jofre, S.A.
Marketing Company Name: Laboratorio Reig Jofre, S.A.
Authorization Date: 2020-12-22
Dosage Form: CÁPSULA DURA
Dose: 0.5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Laboratorio Reig Jofre, S.A.

Active Ingredients

FINGOLIMOD HIDROCLORURO

0,56 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 22, 2020

Approval ID

81a6fd09ffd6fc8c

Type

Standard

Back to CIMA-AEMPS Approvals